Recruiting Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer NCT05098210 Conditions Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more Locations Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States View Trial Details
Recruiting Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial NCT07155317 Conditions Advanced Acral Melanoma, Advanced Cutaneous Melanoma, Advanced Mucosal Melanoma, +19 more Locations Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States Emory Saint Joseph's Hospital — Atlanta, Georgia, United States View Trial Details
